Skip to content
Home
About Us
Team
Job Openings
Antivirals
BK Virus
Immuno-Oncology
Pledge AI
News & Presentations
News
Presentations
Home
About Us
Team
Job Openings
Antivirals
BK Virus
Immuno-Oncology
Pledge AI
News & Presentations
News
Presentations
Menu
Former Novartis Executive Dr. Marie Lindner Joins Orthogon Therapeutics’ Board of Directors
By
November 10, 2025
Prev
Previous
Orthogon Therapeutics Announces an $8m Follow-On Financing to Advance Its Lead BK Virus Drug
Next
Big Pharma faces a cliff edge with the ongoing crisis in Ukraine
Next
Home
About Us
Team
Job Openings
Antivirals
BK Virus
Immuno-Oncology
Pledge AI
News & Presentations
News
Presentations
Home
About Us
Team
Job Openings
Antivirals
BK Virus
Immuno-Oncology
Pledge AI
News & Presentations
News
Presentations
Linkedin
Twitter